Pfizer CEO Albert Bourla criticizes RFK's vaccine stance, warns US health research is losing ground to China, and urges ...

One of these suggested stocks features a dividend yield topping 10%.

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation models.

By Yadarisa Shabong Jan 20 (Reuters) - Britain's GSK and Japan's Shionogi said on Tuesday that Pfizer will exit their HIV ...

Pfizer's been focusing on a hot area of healthcare recently: GLP-1 drugs.

“Stories of Hope” shares the stories of the people and scientists at the forefront of advancing medical science and pushing ...

Pfizer's stock has started to turn higher, but it is still down massively; is now the time to jump aboard?

All three of these stocks sport dividend yields above 6%.

Albert Bourla said Pfizer has discussed a fast-pass voucher with the White House during the JPMorgan Healthcare Conference.

Pfizer remains a Strong Buy, with oncology breakthroughs, a revitalized obesity pipeline, and aggressive cost savings ...

Five months after ending development of its own obesity treatment, Pfizer is accelerating its push into the rapidly growing field with a nearly $5 billion acquisition. An app’s blunt life check adds ...